RxDoctor Payments DataLook up a doctor →

Rachel Neely

Physician Assistant · Atlanta, GANPI 1104353499

Payments from drug & device makers

$44,215in general payments, 2019–2025

Across 898 payments — averaging $49.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$16K
  • Impel Pharmaceuticals Inc.$12K
  • Pfizer$2K
  • UCB, Inc.$1K
  • Upsher-smith Laboratories LLC$1K
  • Lundbeck LLC$1K
  • plus $10K from 46 others

What the payments were for

  • Consulting fees$9,70222%
  • Speaking & faculty fees$13,98032%
  • Travel & lodging$1,3763%
  • Food & beverage$19,15743%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)169$16,019
Impel Pharmaceuticals Inc.71$12,158
Pfizer44$1,613
UCB, Inc.63$1,458
Upsher-smith Laboratories LLC38$1,296
Lundbeck LLC49$1,223
Supernus Pharmaceuticals, Inc.41$1,040
Neurelis, Inc.39$1,034
Teva Pharmaceuticals USA, Inc.41$962
Jazz Pharmaceuticals Inc.27$657
Biohaven Pharmaceuticals, Inc.23$601
Eisai Inc.29$590
Biohaven Pharmaceutical Holding Company Ltd.28$530
Lilly USA, LLC13$457
SK Life Science, Inc.15$422
Amgen16$369
Sumitomo Pharma America, Inc.13$347
Azurity Pharmaceuticals, Inc.21$323
Neos Therapeutics, LP25$269
Ironshore Pharmaceuticals Inc.12$266
Ipsen Biopharmaceuticals, Inc13$246
Sunovion Pharmaceuticals Inc.9$206
Axsome Therapeutics, Inc.9$176
Otsuka America Pharmaceutical, Inc.7$175
Biocodex, Inc.7$162
Catalyst Pharmaceuticals, Inc.7$155
Takeda Pharmaceuticals U.S.A., Inc.10$150
AstraZeneca2$144
Tris Pharma Inc7$131
Immedica Pharma US, Inc.5$121
Scilex Pharmaceuticals Inc.6$109
Acadia Pharmaceuticals Inc5$105
Aquestive Therapeutics, Inc.5$104
Inspire Medical Systems, Inc.1$83
Collegium Pharmaceutical, Inc.5$82
Merz Pharmaceuticals, LLC3$66
Adlon Therapeutics L.p.3$56
Livanova USA, Inc.2$45
Corium, LLC2$31
Otter Pharmaceuticals, LLC1$25
Johnson & Johnson1$25
Noven Therapeutics, LLC1$24
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$23
Nobelpharma America, LLC1$21
Arbor Pharmaceuticals, Inc.1$19
Tonix Medicines, Inc.1$19
Sanofi1$17
Amneal Pharmaceuticals LLC1$16
Currax Pharmaceuticals LLC1$13
Biomarin Pharmaceutical Inc.1$12
Aucta Pharmaceuticals, Inc.1$10
Aytu Biopharma, Inc.1$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$44,215 in reported general payments places this provider in the 95th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
EpidiolexCannabidiol (Cbd)11$47,069
UbrelvyUbrogepant13$14,298

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy$16,019$14,29813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →